Treatment Targeting Is Key to Success in Oncology April 23, 2021 With precision-guided approaches to care establishing themselves across tumor types, newer systemic therapy regimens are almost exclusively developed for the treatment of histological or biomarker subtypes within a larger disease state. One of the most prevalent examples of this is breast cancer, which has seen significant and consistent progress in terms of advancing overall survival in the treatment of HER2-positive tumors.Read the full article here. About Prostate Cancer Progress in Prostate Cancer Research Prostate Cancer News Research Treatment Options More for you
With precision-guided approaches to care establishing themselves across tumor types, newer systemic therapy regimens are almost exclusively developed for the treatment of histological or biomarker subtypes within a larger disease state. One of the most prevalent examples of this is breast cancer, which has seen significant and consistent progress in terms of advancing overall survival in the treatment of HER2-positive tumors.Read the full article here.
About Prostate Cancer Progress in Prostate Cancer Research Prostate Cancer News Research Treatment Options
